Efficacy Trial of a DNA/rAd5 HIV-1 Preventive Vaccine

BACKGROUND: A safe and effective vaccine for the prevention of human immunodeficiency virus type 1 (HIV-1) infection is a global priority. We tested the efficacy of a DNA prime–recombinant adenovirus type 5 boost (DNA/rAd5) vaccine regimen in persons at increased risk for HIV-1 infection in the Unit...

詳細記述

保存先:
書誌詳細
主要な著者: Hammer, Scott M., Sobieszczyk, Magdalena E., Janes, Holly, Karuna, Shelly T., Mulligan, Mark J., Grove, Doug, Koblin, Beryl A., Buchbinder, Susan P., Keefer, Michael C., Tomaras, Georgia D., Frahm, Nicole, Hural, John, Anude, Chuka, Graham, Barney S., Enama, Mary E., Adams, Elizabeth, DeJesus, Edwin, Novak, Richard M., Frank, Ian, Bentley, Carter, Ramirez, Shelly, Fu, Rong, Koup, Richard A., Mascola, John R., Nabel, Gary J., Montefiori, David C., Kublin, James, McElrath, M. Juliana, Corey, Lawrence, Gilbert, Peter B.
フォーマット: Artigo
言語:Inglês
出版事項: 2013
主題:
Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC4030634/
https://ncbi.nlm.nih.gov/pubmed/24099601
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1056/NEJMoa1310566
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料